← Open Payments lookup

CAITLYN KRUSINSKY: Open Payments

NPI 1376388041 · DALLAS, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,797 in 105 payments from 21 companies in 2025. Trend: 2023 $0 · 2024 $803 · 2025 $1,797

Food & beverage: $1,797
CompanyPaymentsAmount
Neurocrine BioSciences, Inc.12$245
Janssen Pharmaceuticals, Inc13$240
ABBVIE INC.24$230
Teva Pharmaceuticals USA, Inc.11$184
Otsuka America Pharmaceutical, Inc.9$175
Vanda Pharmaceuticals Inc.5$145
Lundbeck LLC5$88
Almatica Pharma LLC5$84
Soleno Therapeutics, Inc.2$62
Axsome Therapeutics, Inc.3$51

Products named: INGREZZA, REXULTI, VRAYLAR, INVEGA SUSTENNA, FANAPT, UZEDY, LOREEV XR, AUSTEDO XR.

Industry payments across TX — which companies pay providers there.